Weekly Updates & Resources from CHUG
THE FDA AUTHORIZES BAMLANIVIMAB FOR EMERGENCY USE
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) allowing the emergency use of the unapproved product bamlanivimab as a treatment for high-risk COVID-19 adult and pediatric patients.
CHUG UPDATES: The weather is changing and CHUG is here with guidance on navigating cold weather emergencies to avoid injuries like frostbite and hypothermia.
Additional Resource Library:
HHS: More Than 2M Patients Affected by Breaches Reported in October
Who Will Be the First to Get COVID-19 Vaccines?
Family Members Getting Jobs in Nursing Homes to see Loved Ones
Monument Health Understaffed, Near-Capacity, as Elderly Wait for Long-Term Care Openings